Advertisement

Topics

Transgene Company Profile

11:19 EST 22nd November 2017 | BioPortfolio

TRANSGENE is a leading integrated gene therapy company, dedicated to the discovery and development of gene delivery technologies and gene therapy products for the treatment of acquired and inherited diseases. The Company's proprietary technology platform consists of five vector families including three of viral origin - adenovirus, retrovirus, vaccinia virus - and two of non viral origin - cellular and synthetic vectors.

Location

11 rue de Molsheim
Strasbourg
F-67082
France

Contact

Phone: 00 33 88 27 91 00
Fax: 00 33 88 27 91 11


News Articles [72 Associated News Articles listed on BioPortfolio]

Transgene (TNG) - Multiple assets in the clinic as data readouts near

Edison Investment Research - Pharmaceutical & healthcare - Transgene: Transgene’s strategy is focused on combining its products with approved therapies with the aim of improving response rates i...

Servier, Transgene team up to improve tech for CAR T-cell treatments

Servier and Transgene have entered into a three-year research partnership that will analyze how Transgene's viral vectorizati -More- 

Transgene Pockets €14.4M for Anti-Cancer Combinations

Transgene has raised another €14.4M from European and US investors. The money will support the development of its pipeline. Transgene, a biotech that develops viral-based immunotherapies, has annou...

Transgene Launches a Capital Increase by Way of an Accelerated Book-Build Offering

Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG) ("Transgene" or the"Company"), a biotech company that designs and develops viral-based immunotherapies, today announced the launch of a...

Transgene Resurgence? First Patients Dosed with Oncolytic Virus

Transgene has commenced a Phase I/IIa trial investigating its oncolytic virus for the treatment of glioblastoma, which will deliver results in 2018. It has been a busy month or two for Transgene, with...

Update: Transgene and BMS Upgrade their Lung Cancer Combination to First Line

Update (12/09/2017): The FDA has cleared Transgene to start Phase II trials with TG4010 in combination with BMS’ Opdivo (nivolumab) as a first-line treatment for advanced, non-squamous non-smal...

Transgene signs deal to develop multifunctional oncolytics

French biotech Transgene and Northern Ireland-based Randox Laboratories, a global leader in in vitro…

TRANSGENE: Peer Reviewed Scientific Publications Highlight TG4010???s Ability To Induce Broad CD8+ Responses And Its Synergistic Effects In Combination With Immune Checkpoint Inhibitors

Transgene Is Currently Developing TG4010 in Advanced Lung Cancer (NSCLC) in Combination Regimens with Immune Checkpoint Inhibitors (ICIs) STRASBOURG, France--(BUSINESS WIRE)--Regulatory...

Drugs and Medications [0 Results]

None

PubMed Articles [75 Associated PubMed Articles listed on BioPortfolio]

Generation of transgenic marmosets using a tetracyclin-inducible transgene expression system as a neurodegenerative disease model.

Controllable transgene expression systems are indispensable tools for the production of animal models of disease to investigate protein functions at defined periods. However, in non-human primates tha...

Single-event transgene-product levels predict levels in genetically modified breeding stacks.

The concentration of transgene products (proteins and double-stranded RNA) in genetically modified (GM) crop tissues is measured to support food, feed, and environmental risk assessments. Measurement ...

A short synthetic chimeric sequence harboring matrix attachment region/PSAR2 increases transgene expression in Chinese hamster ovary cells.

A chimeric DNA fragment containing an interferon-beta matrix attachment region (MAR) and an immunoglobulin MAR (PSAR2) was synthesized. PSAR2 was cloned into the upstream or downstream region of an en...

Identification of a potent MAR element from the human genome and assessment of its activity in stably transfected CHO cells.

Low-level and unstable transgene expression are common issues using the CHO cell expression system. Matrix attachment regions (MARs) enhance transgene expression levels, but additional research is nee...

Genetically engineered rice endogenous 5-enolpyruvoylshikimate-3-phosphate synthase (epsps) transgene alters phenology and fitness of crop-wild hybrid offspring.

Genetically engineered (GE) rice endogenous epsps (5-enolpyruvoylshikimate-3-phosphate synthase) gene overexpressing EPSPS can increase glyphosate herbicide-resistance of cultivated rice. This type of...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation

The primary objective is to evaluate the transgene expression (synthesis of FGF-1 mRNA) in injected tissue, at injection site, after Intra Muscular (IM) administration of increasing single...

Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured

Activation of the immune system against a pathogen can be considered one of the most effective interventions in the field of infectious diseases. Transgene is developing a therapeutic vac...

MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)

This is a Phase I-II study evaluating the feasibility, safety, and efficacy of swallowed MnSOD plasmid/liposome (PL) transgene given as protection against radiation-induced esophagitis dur...

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic metabolic disorder characterized by absent or severely reduced capacity to catabolize circulating LDL particles by the hep...

Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)

The inherited retinal dystrophies are a clinically and genetically heterogeneous group of conditions, which often present in childhood.Inherited retinal degenerations cause sight impairmen...

Companies [8 Associated Companies listed on BioPortfolio]

Transgene S.A.

Transgene (Euronext: TNG), part of Institut Mérieux, is a publicly traded French biopharmaceutical company focused on discovering and developing targeted immunotherapies for th...

Transgene SA

Transgene (NYSE-Euronext: TNG), a member of the Institut Mérieux Group, is a biopharmaceutical company. It creates, develops and manufactures targeted immunotherapeutics for th...

Transgene

TRANSGENE is a leading integrated gene therapy company, dedicated to the discovery and development of gene delivery technologies and gene therapy products for the treatment of acquired and inherited d...

Intrexon Corporation

Intrexon Corporation is a privately held life sciences company that employs modular DNA control systems to enhance capabilities, improve safety and lower cost in human therapeutic...

Transgene Inc

Mission StatementTransgene is a biopharmaceutical company dedicated to the discovery and development of gene-based therapeutic vaccines and immunotherapy products for the treatment of cancer and infec...

More Information about "Transgene" on BioPortfolio

We have published hundreds of Transgene news stories on BioPortfolio along with dozens of Transgene Clinical Trials and PubMed Articles about Transgene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Transgene Companies in our database. You can also find out about relevant Transgene Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record